Indaptus Therapeutics, Inc.

INDP · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$15-$15-$14-$8
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$6
Stock-Based Comp.$2$3$3$2
Change in WC$0-$1-$2-$5
Other Non-Cash$0-$0-$0$6
Operating Cash Flow-$12-$13-$13-$11
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$7-$30$0
Inv. Sales/Matur.$0$24$13$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$17-$16$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$6$0$0$5
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1$0$0$43
Financing Cash Flow$5$0$0$48
Forex Effect$0$0$0$0
Net Chg. in Cash-$8$4-$30$37
Supplemental Information
Beg. Cash$13$10$39$2
End Cash$6$13$10$39
Free Cash Flow-$12-$13-$13-$11
Indaptus Therapeutics, Inc. (INDP) Financial Statements & Key Stats | AlphaPilot